For research use only. Not for therapeutic Use.
Zelnecirnon（Cat No.:I042896）is an investigational peptide inhibitor currently being researched for its potential in treating various inflammatory diseases, particularly in the realm of immune system regulation. This compound targets specific signaling pathways involved in immune response modulation, with a focus on controlling excessive inflammation. Through its mechanism of action, Zelnecirnon may help reduce symptoms in autoimmune conditions and chronic inflammatory diseases, offering a novel therapeutic option. Though still under clinical investigation, Zelnecirnon holds promise as a key player in the development of next-generation treatments for immune-related disorders.
| CAS Number | 2366152-15-8 |
| Synonyms | 3-[(3R)-3-[1-[5-chloro-4-[[(1R)-1-(2,4-dichlorophenyl)ethyl]amino]-6-methylpyrimidin-2-yl]azetidin-3-yl]piperidin-1-yl]-1-methylcyclobutane-1-carboxylic acid |
| Molecular Formula | C27H34Cl3N5O2 |
| Purity | ≥95% |
| IUPAC Name | 3-[(3R)-3-[1-[5-chloro-4-[[(1R)-1-(2,4-dichlorophenyl)ethyl]amino]-6-methylpyrimidin-2-yl]azetidin-3-yl]piperidin-1-yl]-1-methylcyclobutane-1-carboxylic acid |
| InChI | InChI=1S/C27H34Cl3N5O2/c1-15(21-7-6-19(28)9-22(21)29)31-24-23(30)16(2)32-26(33-24)35-13-18(14-35)17-5-4-8-34(12-17)20-10-27(3,11-20)25(36)37/h6-7,9,15,17-18,20H,4-5,8,10-14H2,1-3H3,(H,36,37)(H,31,32,33)/t15-,17+,20?,27?/m1/s1 |
| InChIKey | ANPSFQZLPNWKHR-PRZTZBHNSA-N |
| SMILES | CC1=C(C(=NC(=N1)N2CC(C2)[C@H]3CCCN(C3)C4CC(C4)(C)C(=O)O)N[C@H](C)C5=C(C=C(C=C5)Cl)Cl)Cl |
